PITA (Q3989611): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Fix Beneficiary from Netherlands) |
(Changed an Item: Fix Beneficiary from Netherlands) |
||
Property / beneficiary name (string) | |||
Omnigen B.V. | |||
Property / beneficiary name (string): Omnigen B.V. / rank | |||
Normal rank | |||
Property / beneficiary | |||
Property / beneficiary: Q3987626 / rank | |||
Normal rank |
Revision as of 09:45, 16 December 2021
Project Q3989611 in Netherlands
Language | Label | Description | Also known as |
---|---|---|---|
English | PITA |
Project Q3989611 in Netherlands |
Statements
332,936.36 Euro
0 references
1,384,837.09 Euro
0 references
24.042 percent
0 references
15 February 2021
0 references
31 December 2023
0 references
Erasmus Universitair Medisch Centrum Rotterdam
0 references
Omnigen B.V.
0 references
3000 CA
0 references
2624 AK
0 references
Ontwikkeling van een digitale tool genaamd PITA, een veelbelovende gepersonaliseerde voorspelling instrument m.b.t. Alvleesklierkanker, waardoor de behandelstrategie en kwaliteit van leven voor deze patiëntengroep aanzienlijk kan worden verbeterd. (Dutch)
0 references
Development of a digital tool called PITA, a promising personalised prediction tool for pancreatic cancer, which can significantly improve the treatment strategy and quality of life for this patient group. (English)
15 December 2021
0 references
Développement d’un outil numérique appelé PITA, un outil de prédiction personnalisé prometteur pour le cancer du pancréas, qui peut améliorer considérablement la stratégie de traitement et la qualité de vie de ce groupe de patients. (French)
15 December 2021
0 references
Entwicklung eines digitalen Tools namens PITA, einem vielversprechenden personalisierten Vorhersagewerkzeug für Bauchspeicheldrüsenkrebs, das die Behandlungsstrategie und Lebensqualität für diese Patientengruppe erheblich verbessern kann. (German)
15 December 2021
0 references
Identifiers
OP-2014-2023-West-KVW-00381
0 references